Fig. 7: Elevated expression of methylated HBP1 and reduced levels of GSN in cervical cancer samples are associated with poorer clinical outcomes. | Oncogenesis

Fig. 7: Elevated expression of methylated HBP1 and reduced levels of GSN in cervical cancer samples are associated with poorer clinical outcomes.

From: Methylation of HBP1 by PRMT1 promotes tumor progression by regulating actin cytoskeleton remodeling

Fig. 7

A–C High level of HBP1 methylation and low GSN expression relate to poor prognosis. A, B IHC assays were performed using anti-HBP1 R378me1a and anti-GSN in 70 cervical cancer tissue samples. Representative images were presented. Scale bar, 50 µm. (n = 70, Student’s t-test) C Correlation between HBP1 R378me1a and GSN expression was examined by Pearson correlation coefficient test.

Back to article page